Angela Holder

ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.

Peter D. Davis, Graeme J. Dougherty, David C. Blakey et al. · Oxford University Research Archive (ORA) (University of Oxford) · 2002 · 231 citations

Endothelial Cell Morphology, Chemoprevention Strategy, Tumor Biology +17

A Duchenne Muscular Dystrophy Gene Hot Spot Mutation in Dystrophin-Deficient Cavalier King Charles Spaniels Is Amenable to Exon 51 Skipping

Gemma Walmsley, Virginia Arechavala‐Gomeza, Marta Fernández-Fuente et al. · PLoS ONE · 2010 · 126 citations · Full text

Autoantibodies to Vimentin Cause Accelerated Rejection of Cardiac Allografts

Balakrishnan Mahesh, Hon S. Leong, Ann McCormack et al. · American Journal Of Pathology · 2007 · 118 citations · Full text

Heart Failure, Transplantation, Autoimmune Disease +8

Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy

Maja Čemažar, C.S. Parkins, Angela Holder et al. · British Journal of Cancer · 2001 · 106 citations · Full text

TLR5 Risk-Associated Haplotype for Canine Inflammatory Bowel Disease Confers Hyper-Responsiveness to Flagellin

Aarti Kathrani, Angela Holder, Briän Catchpole et al. · PLoS ONE · 2012 · 58 citations · Full text

Tlr5 Gene, Immunodeficiencies, Immunology +27